bezafibrate has been researched along with Cholangitis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreyro, FJ; Daruich, J; González Ballerga, E; Sorda, JA | 1 |
| Banales, JM; Rodrigues, PM | 1 |
| Bowlus, CL; Liu, CH | 1 |
| Levy, C; Lindor, KD | 1 |
| Abergel, A; Admane, FH; Boursier, J; Bronowicki, JP; Chazouillères, O; Chollet-Martin, S; Corpechot, C; de Chaisemartin, L; de Ledinghen, V; Debette-Gratien, M; Gaouar, F; Goria, O; Habersetzer, F; Heurgue-Berlot, A; Humbert, L; Larrey, D; Le Gruyer, A; Lefèvre, G; Lemoinne, S; Mathurin, P; Minello, A; Nguyen-Khac, E; Nkontchou, G; Ollivier-Hourmand, I; Potier, P; Poupon, R; Rainteau, D; Rousseau, A; Roux, O; Silvain, C; Simon, T; Zarski, JP; Zoulim, F | 1 |
| Chazouillères, O; Corpechot, C; Rousseau, A | 1 |
| Hegade, VS; Jones, DE | 1 |
| Chazouillères, O; Chollet-Martin, S; Corpechot, C; De Chaisemartin, L; Humbert, L; Kremer, AE; Le Cleac'h, A; Lemoinne, S; Poupon, R; Rainteau, D; Rousseau, A; Wolf, K | 1 |
| Korula, J | 1 |
| Klose, G; Nitschmann, S | 1 |
| Chazouillères, O; Corpechot, C; Lemoinne, S; Rousseau, A | 1 |
| Abe, M; Arakawa, M; Fujii, H; Hashimoto, N; Honda, A; Iimuro, S; Inao, M; Itakura, J; Joshita, S; Kakisaka, K; Kaneko, A; Kaneko, T; Kang, JH; Kawada, N; Kawata, K; Kikuchi, K; Komori, A; Masaki, T; Matsuzaki, Y; Mochida, S; Namisaki, T; Ninomiya, M; Nomura, T; Ohira, H; Sato, K; Takahashi, A; Takikawa, H; Takikawa, Y; Tanaka, A; Umemura, T; Yamagiwa, S; Yoshiji, H | 1 |
1 review(s) available for bezafibrate and Cholangitis
| Article | Year |
|---|---|
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies.
Topics: Autoimmune Diseases; Bezafibrate; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
1 trial(s) available for bezafibrate and Cholangitis
| Article | Year |
|---|---|
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Topics: Adult; Bezafibrate; Bile Acids and Salts; Cholangitis; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Treatment Failure; Ursodeoxycholic Acid | 2018 |
10 other study(ies) available for bezafibrate and Cholangitis
| Article | Year |
|---|---|
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply.
Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet?
Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |
Editorial: Itching to Know: Role of Fibrates in PBC.
Topics: Bezafibrate; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid | 2018 |
Bezafibrate in Primary Biliary Cholangitis.
Topics: Bezafibrate; Cholangitis; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary | 2018 |
Bezafibrate in Primary Biliary Cholangitis.
Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2018 |
Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis.
Topics: Antipruritics; Bezafibrate; Cholangitis; Gastroenterology; Humans; Liver Cirrhosis, Biliary; United Kingdom | 2019 |
In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response.
Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2018 |
[Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial].
Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2018 |
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response.
Topics: Bezafibrate; Cholangitis; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid | 2019 |
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.
Topics: Adult; Aged; Aged, 80 and over; Bezafibrate; Cholangitis; Female; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2019 |